IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Kedem Pharmaceuticals Inc

CUSIP: 48723P109 | 3 institutional holders

Quarters

Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2024

FTB Advisors, Inc.125
0.0% of portfolio›$0
StyleTurnoverLocationFiled
FTB Advisors, Inc.
125$00.0%GrowthVery LowMemphis, TN2024-11-08